Sheng Cao

Sheng Cao

Auto-generated profile, based on publicly available information

Sheng Cao

School of Life Science, Beijing Institute of Technology, Beijing, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2023 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
SCSheng Cao
Sheng Cao
SGShuoxin Gu
Shuoxin Gu
JGJian Guo
Jian Guo
JWJian Wang
Jian Wang
YZYongxin Zhang
Yongxin Zhang
JLJian-Min Liu
Jian-Min Liu
The cardio-cerebrovascular disease is a significant disease that can directly threaten life and health. Vascular intervention surgery is currently the mainstream treatment method. This kind of surgery requires doctors to be exposed to radiation for a long, with extensive body damage. In response, domestic and foreign researchers began to develop endovascular intervention surgery robots. Although the robot has specific additional capabilities, it is still in the research and development stage. It must continuously improve performance, reliability, and functionality before it can be used in interventional surgery. Therefore, to further reduce doctors’ learning and training costs, optimize the operation steps in surgery, and improve delivery accuracy. We developed a reciprocating delivery device-based endovascular intervention robot with multi-manipulators collaboration. The third-party type test confirmed that the robot’s feasibility and overall performance meet the surgery’s needs (Average linear accuracy is less than 0.1mm). In-vivo experiments have demonstrated the efficacy, safety, and reduction of radiation exposure to doctors (nearly 98.68%).